Evidence map›Paper›PMID 21205042›Full record

ArticleAddiction (Abingdon, England)2011

Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs.

John H Halpern, Andrea R Sherwood, James I Hudson, Staci Gruber, David Kozin, Harrison G Pope

Abstract read
In one paragraph

Article in Addiction (Abingdon, England), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 117 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Worsening of the Toxic Effects of (±)International journal of molecular sciences · 2021
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

John H HalpernLaboratory for Integrative Psychiatry Biological Psychiatry Laboratory Cognitive and Clinical Neuroimaging Core Brain Imaging Center McLean Hospital, Belmont, MA, USA.
Andrea R Sherwood
James I Hudson
Staci Gruber
David Kozin
Harrison G Pope
Cognitive Neuroimaging Lab · FRHarvard University · USLaboratoire d’immunologie intégrative du cancer · FRMcLean Hospital · US

Funding

Neurocognitive Consequences of Long-Term Ecstasy UseR01DA017953 · NIDA · MC LEAN HOSPITAL (BELMONT, MA) · PI HALPERN, JOHN HAIM · 2004 to 2008
$1.8M
NIDA NIH HHS DA017953NIDA NIH HHS R01 DA017953
6 · The paper itself

Abstract

aimsIn field studies assessing cognitive function in illicit ecstasy users, there are several frequent confounding factors that might plausibly bias the findings toward an overestimate of ecstasy-induced neurocognitive toxicity. We designed an investigation seeking to minimize these possible sources of bias.

designWe compared illicit ecstasy users and non-users while (1) excluding individuals with significant life-time exposure to other illicit drugs or alcohol; (2) requiring that all participants be members of the 'rave' subculture; and (3) testing all participants with breath, urine and hair samples at the time of evaluation to exclude possible surreptitious substance use. We compared groups with adjustment for age, gender, race/ethnicity, family-of-origin variables and childhood history of conduct disorder and attention deficit hyperactivity disorder. We provide significance levels without correction for multiple comparisons.

settingField study.

participantsFifty-two illicit ecstasy users and 59 non-users, aged 18-45 years. MEASUREMENTS: Battery of 15 neuropsychological tests tapping a range of cognitive functions.

findingsWe found little evidence of decreased cognitive performance in ecstasy users, save for poorer strategic self-regulation, possibly reflecting increased impulsivity. However, this finding might have reflected a pre-morbid attribute of ecstasy users, rather than a residual neurotoxic effect of the drug.

conclusionsIn a study designed to minimize limitations found in many prior investigations, we failed to demonstrate marked residual cognitive effects in ecstasy users. This finding contrasts with many previous findings-including our own-and emphasizes the need for continued caution in interpreting field studies of cognitive function in illicit ecstasy users.

Indexed as

AdolescentAdultCase-Control StudiesChronic DiseaseCognitionCognition DisordersConfounding Factors, EpidemiologicDancingDose-Response Relationship, DrugFemaleHallucinogensHumansImpulsive BehaviorLinear ModelsMaleMemoryHallucinogensN-Methyl-3,4-methylenedioxyamphetamineSerotonin Agents

Identifiers

PMID21205042
PMCPMC3053129
OpenAlexW2145452630

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.